Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chidamide”

222 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 222 results

Testing effectiveness (Phase 2)Looking for participantsNCT07514936
What this trial is testing

Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia

Who this might be right for
Newly Diagnosed Acute Myeloid Leukemia (AML)Elderly Patients
Chinese PLA General Hospital 120
Testing effectiveness (Phase 2)UnknownNCT05438706
What this trial is testing

A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Fudan University 70
Testing effectiveness (Phase 2)UnknownNCT05400993
What this trial is testing

Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC

Who this might be right for
Breast Cancer
Shengjing Hospital 59
Not applicableUnknownNCT05047848
What this trial is testing

Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Liaoning Cancer Hospital & Institute 82
Testing effectiveness (Phase 2)UnknownNCT05951855
What this trial is testing

Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients

Who this might be right for
Acute Myeloid Leukemia (Relapsed/Refractory)
The First Affiliated Hospital of Soochow University 42
Testing effectiveness (Phase 2)UnknownNCT02987244
What this trial is testing

Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma

Who this might be right for
T Cell Non-Hodgkin's Lymphoma
Peking Union Medical College Hospital 100
Testing effectiveness (Phase 2)UnknownNCT04724239
What this trial is testing

Sintilimab and Chidamide in Combination With or Without IBI305 in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma

Who this might be right for
Advanced Microsatellite Stable Colorectal CancerMetastatic Microsatellite-stable Colorectal Cancer
Sun Yat-sen University 48
Testing effectiveness (Phase 2)UnknownNCT02944812
What this trial is testing

Chidamide for Refractory/Relapsed Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Guangdong Provincial People's Hospital 12
Testing effectiveness (Phase 2)UnknownNCT03630731
What this trial is testing

Maintenance Treatment of Chidamide in Stage IV or Relapsed/Refractory Extranodal NK/T-cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Chinese Academy of Medical Sciences 32
Testing effectiveness (Phase 2)Study completedNCT03974243
What this trial is testing

Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin's Lymphoma
Chipscreen Biosciences, Ltd. 9
Testing effectiveness (Phase 2)Looking for participantsNCT06570447
What this trial is testing

Glofitamab Combination With Chidamide in Patients With Recurrent/Refractory DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma-RecurrentDiffuse Large B-Cell Lymphoma-Refractory
Tianjin Medical University Cancer Institute and Hospital 22
Not applicableEnrolling By InvitationNCT05690191
What this trial is testing

Chidamide in Patients With Recurrent and Refractory Diffuse Large b

Who this might be right for
Diffuse Large B-cell Lymphoma
Second Affiliated Hospital of Soochow University 169
Testing effectiveness (Phase 2)Study completedNCT03985007
What this trial is testing

CDIAG Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia, Relapsed, Adult
The First Affiliated Hospital of Soochow University 40
Testing effectiveness (Phase 2)UnknownNCT04329130
What this trial is testing

Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Who this might be right for
Relapsed or Refractory Peripheral T-cell Lymphoma
Sun Yat-sen University 44
Testing effectiveness (Phase 2)UnknownNCT04480125
What this trial is testing

Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy

Who this might be right for
Peripheral T-cell Lymphoma
Ruijin Hospital 28
Testing effectiveness (Phase 2)UnknownNCT04337606
What this trial is testing

Chidamide in Combination With Decitabine in Non-Hodgkin's Lymphoma Relapsed After Chimeric Antigen Receptor

Who this might be right for
Non Hodgkin Lymphoma
Chinese PLA General Hospital 100
Large-scale testing (Phase 3)UnknownNCT02902185
What this trial is testing

Chidamide in Combination With ART for Reactivation of the Latent HIV-1 Reservoir

Who this might be right for
Chronic HIV Infections
Tang-Du Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT07518602
What this trial is testing

Efficacy and Safety of Chidamide+Sintilimab+Bev as Second-Line Therapy in Advanced Extrapulmonary Neuroendocrine Carcinoma

Who this might be right for
Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)
Sun Yat-sen University 34
Not applicableLooking for participantsNCT06386302
What this trial is testing

Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
AMLAcute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 184
Testing effectiveness (Phase 2)UnknownNCT03321890
What this trial is testing

Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Peripheral T-cell Lymphoma
Sun Yat-sen University 102
Load More Results